Skyline New York clear_16x9

About Us

WACKER in North America

Whether it’s protecting buildings from the elements, a tube of toothpaste or a cell phone, airbags, diving goggles or furniture polish: people all over the world come into contact everyday with our products and achievements, often without noticing. As the North American based headquarters for Wacker Chemie AG, Wacker Chemical Corporation develops solutions and technologies and manufactures products for applications both here in the Americas and around the globe.

The WACKER Group’s U.S. activities began in 1965, when the Munich-based chemical company established Wacker Chemicals Corporation in New York. This move provided WACKER with direct access to North American markets. In the U.S., WACKER now operates six production sites, five sales offices and has twenty-one distributors, thus ensuring close proximity to its customers. North and South America is one of WACKER’s most important forward-looking markets, accounting for around 18 percent of global Group sales €4.7 billion (2020).

The Group’s WACKER SILICONES, WACKER POLYSILICON, WACKER POLYMERS and WACKER BIOSOLUTIONS business divisions are represented in the United States by Wacker Chemical Corporation in Adrian, Michigan.

The Numbers Behind the Success Story

1.2 %

increase in regional sales

4000

tankers of VAE dispersions each year

6380

specialists trained at the WACKER NCA ACADEMY since 2012

1200

unique release coatings created in our lab every year

Pharmaceutical Manufacturing in the US

In 2021, WACKER strengthened its business by adding a pharmaceutical contract development and manufacturing organization (CDMO) location for plasmid DNA (pDNA) based in San Diego, Calif. The demand for pDNA has risen sharply in recent years. This new WACKER location includes a capacity up to 500 liters for the production and purification of pDNA. For decades, WACKER has been manufacturing therapeutic proteins, living microbial products and vaccines for clinical development as well as commercial supply. This proprietary pDNA technology enhances WACKER's portfolio and creates a U.S. presence in serving as a contract manufacturer for the pharmaceutical industry.